Medical Radiology and Radiation Safety. 2021. Vol. 66. № 3. P. 48–54

I.L. Bukhovets¹, O.Ya. Vasiltseva^1,2, Yu.B. Lishmanov^1,2, I.N. Vorozhtsova^1,3, A.G. Lavrov³, 
E.A. Ivanovskaya⁵, A.M. Cherniavskii², W.Yu. Ussov^1,2

Design and Clinical Evaluation of Pharmacologic Stress-Test with Dalargin
for SPECT Detection of Viable Myocardium in Patients after Myocardial Infarction

¹ Cardiology Research Institute, Tomsk National Medical Research Center, Tomsk, Russia

² E.N. Meshalkin National Medical Research Center, Novosibirsk, Russia  

³ National Research Tomsk Polytechnic University, Tomsk, Russia

⁴ Siberian State Medical University, Tomsk, Russia

⁵ Novosibirsk State Medical University, Novosibirsk, Russia

 Contact person: Wladimir Yurievich Ussov: This email address is being protected from spambots. You need JavaScript enabled to view it.

Abstract

Purpose: To develop a functional stress-test with Dalargin used as a pharmacological stress agent and to study its diagnostic capabilities for quantifying the general and segmental systolic function of the left ventricle in patients with IHD using SPECT and echo methods.

Material and methods: The study comprised 29 male patients with CHD-angina of 2-3 functional classes, studied on 15–25 days (on average 20 ± 2.8 days) after a large-focal myocardial infarction. A fractional step-wise injection of Dalargin was performed with step doses as 0.1 mg / kg (1 ml up to a total of 8 ml, with intervals of 90 seconds, for a total of 12 minutes), in a supine position. After each dose of Dalargin, blood pressure, heart rate, ECG were recorded, and an echocardiographic assessment of hemodynamic parameters and local contractility was carried out. At the peak of the effect of dalargin, 99mTc-Tetrofosmin was administered intravenously (370 – 540 MBq), followed by chest SPECT.

Results: The optimal dose of dalargin for assessing the contractility of the LV was 0.3 mg/kg. From the data of myocardial perfusion SPECT, at dalargin test, the number of segments with normal regional blood supply increased statistically significantly from 56,0 % to 64,7 %, the number of hypoperfused segments decreased from 41.0% to 33.7% as compared to rest, and the number of non-perfused ones – from 3.0 % to 1.6 %. Spearman’s correlation coefficient between segmental contractility and local perfusion at the top dalargin inotropic effect was high and significant (R=0.67, p<0.01). The sensitivity and specificity of the pharmacological test with intravenous administration of dalargin for prediction of postoperative improvement of perfusion and contractility of the viable myocardium were: sensitivity 78.8 %, specificity 76.4 %, diagnostic accuracy 77.6 %.

Conclusion. The use of the agonist of the μ - and δ-opioid receptors dalargin as a pharmacological stress-agent at perfusion SPECT and Stress Echocardiography to assess the contractile reserve of a dysfunctional viable myocardium is informative and appropriate. In patients with IHD who have suffered a myocardial infarction and are referred to  myocardial revascularization, dalargin can be employed as an effective stress-agent for assessing the reserve of perfusion and contractility of dysfunctional left ventricular myocardium using perfusion  SPECT and echocardiography.

Key words: SPECT, myocardial blood flow, functional reserve, dalargin, dalargin functional test, heart ultrasound

For citation: Bukhovets IL, Vasiltseva OYa, Lishmanov YuB, Vorozhtsova IN, Lavrov AG, Ivanovskaya EA, Cherniavskii AM, Ussov WYu. Design and Clinical Evaluation of Pharmacologic Stress-Test with Dalargin for SPECT Detection of Viable Myocardium in Patients after Myocardial Infarction. Medical Radiology and Radiation Safety. 2021;66(3):48-54.

DOI: 10.12737/1024-6177-2021-66-3-48-54

References

1. Maslov LN, Lishmanov YuB, Maryzhnaya NV. Opioidergic Component of Morpho-functional Changes in Myocardium in Stress and Adaptation. Tomsk, STT Publ., 2003. 237 p. (In Russian).
2. Ussov WYu, Efimova IYu, Plotnikov MP, Karpov RS. Patterns of Cerebral Blood Flow Reactivity in Adenosine Stress-test in Patients with Carotid Stenosis, Evaluated with MRI and 99mTc-HMPAO SPECT Brain study. Vestnik Rentgenologii i Radiologii = Russ. J. Radiol. 2000;6:4-9 (In Russian).
3. Aronov DM, Lupanov VP. Functional Tests in Cardiology. Moscow, Medpress-Inform, Publ., 2007 (In Russian).
4. Borisenko VG, Gubareva EA, Kade AH. Myocardial Reactions to Ischemia. Therapeutic Archive. 2010;82;3:64-67 (In Russian).
5. Bydanova SS, Kiryanova AN, Leshchinskii LA, Bydanov SA. Clinical Efficiency of Application of an Analogue of Endogenous Neuropeptides Dalargin in Complex Therapy of Acute Coronary Syndrome. Practical Medicine. 2004;1;6:22-23 (In Russian).
6. Griffin B, Topol E. Cardiology. Moscow, Praktika, Publ., 2008 (In Russian).
7. 7. Maslov LN, Naryzhnaya NV. Receptor Mechanisms and Signaling of Myocardial Protection Against Ischemic – Reperfusion Damage. Tomsk, University of Control Systems and Radioelectronics Publ., 2018. 352 p. (In Russian).
8. Ansheles AA, Sergienko IB, Denisenko-Kankiya EI, Sergienko VB. Myocardial Perfusion SPECT and Coronary Angiography Results in Patients with Different Pre-Test Probability of Ishemic Heart Disease. Therapeutic Archive. 2020;92;4:30-36 (In Russian). DOI:10.26442/00403660.2020.04.000549.
9. Migrino RQ, Xiaoguang Zhu, Pajewski N. Assessment of Segmental Myocardial Viability Using Regional 2-dimensional Strain Echocardiography. Journal of the American Society of Echocardiography. 2007;20;4:342-351. DOI:10.1016/j.echo. 2006.09.011.
10. Dontsov AV. Possibilities of Dalargin in Treatmen of Patients Ischemic Heart Disease. Digest of New Medical Technologies. 2012;19;3:159-161 (In Russian).
11. Lishmanov YuB, Makarova EV, Chernov VI, Vesnina JV, Babokin VE, Vorozhtsova IN, Bukhovets IL. I99Tl Reinjection Combined with SPECT Imaging in Myocardium Hibernation Diagnosis. Medical Radiology and Radiation Safety. 2005;50;1:62-67 (In Russian).
12. Saidova MA. Current Methods of Detection of Viable Myocardium. Kardiologia. 2005;9: 47-54 (In Russian).
13. Rosa S, Lauro C. The Clinical use of Stress Echocardiography in Ischemic Heart Disease. Cardiovascular Ultrasound. 2017;15:7. DOI 10.1186/s12947-017-0099-2.
14. Vorozhtsova IN, Bukhovets IL, Bezlyak VV, Babokin VE, Lishmanov YuB. Prognostication of Hemodynamic Efficacy of Surgical Correction of Chronic Coronary Insufficiency Based on Stress test with Nitroglycerine. Cardiologia. 2003;6:23-27 (In Russian).
15. Lishmanov YuB, Maslov LN. Ishemic Post-Conditioning of the Heart. Receptor Mechanisms and Possibilities of Clinical Applications. Cardiologia. 2010;6:68-74 (In Russian).
16. Rybakova MK, Alekhin MN, Mit’kov VV. Echocardiohgraphy: Practical Guidebook in Ultrasound Diagnosis. Moscow, Vidar-M Publ., 2008. 544 p. (In Russian).
17. Ross J. Myocardial Perfusion-Contraction Matching. Implications for Coronary Heart Disease and Hibernation. Circulation. 1991;83:1076-1083.

 PDF (RUS) Full-text article (in Russian)

Conflict of interest. The authors declare no conflict of interest.

Financing. The study had no sponsorship.

Contribution. Development of the concept and design of the study: Usov V.Yu., Bukhovets I.L., Vasiltseva O.Ya., Chernyavsky A.M., Lishmanov Yu.B.; Obtaining, analysis and scientific interpretation of data: Vasiltseva O.Ya., Bukhovets I.L., Lavrov A.G., Vorozhtsova I.N., Ivanovskaya E.A., Lishmanov Yu.B., Usov V.Yu.; Substantiation of the manuscript and verification critical intellectual content: Bukhovets I.L., Lavrov A.G., Vorozhtsova I.N., Chernyavsky A.M., Usov V.Yu.; Final approval of the manuscript for publication: Bukhovets I.L., Vasiltseva O.Ya., Lishmanov Yu.B., Chernyavsky A.M., Usov V.Yu.

Article received: 18.08.2020.

Accepted for publication: 19.01.2021